Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-460801

Principal Financial Officer bought 10,000 shares at $0.65 ($6,500)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alfieri Michael Principal Financial Officer 2026-11-11 Purchase +10,000 $0.65 $6,500 17,500 D
Open-market purchases · 10,000 sh · avg $0.65 · $6,500
Loading xslF345X06/ownership.xml…